Search
Close this search box.

ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix

ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix -Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment of uterine fibroids- –Financing agreement with JGB Management to fund the planned launch of linzagolix as well as other development and operational expenses– – Amendment of Kissei exclusive license […]

GA-ASI Completes European Maritime Demos

Five-Week Flight Series Featuring SeaGuardian® Includes Multiple Industry Firsts Featured Image for General Atomics Aeronautical Systems, Inc. SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — General Atomics Aeronautical Systems Inc. (GA-ASI) completed a series of flight demonstrations that featured a company-owned MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) in partnership with the Royal Air Force (RAF). […]

POPULAR POSTS